BrainsWay Past Earnings Performance

Past criteria checks 0/6

BrainsWay's earnings have been declining at an average annual rate of -3.2%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 10% per year.

Key information

-3.2%

Earnings growth rate

13.4%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate10.0%
Return on equity-10.1%
Net Margin-13.2%
Next Earnings Update08 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How BrainsWay makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:BRSY.F Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2332-4227
30 Sep 2329-8237
30 Jun 2326-13258
31 Mar 2326-14268
31 Dec 2227-13258
30 Sep 2230-11258
30 Jun 2233-8247
31 Mar 2232-7237
31 Dec 2130-6226
30 Sep 2128-6206
30 Jun 2126-5186
31 Mar 2124-5175
31 Dec 2022-5166
30 Sep 2021-7176
30 Jun 2021-9187
31 Mar 2022-12208
31 Dec 1923-10198
30 Sep 1922-10178
30 Jun 1920-9157
31 Mar 1918-7136
31 Dec 1816-6126
30 Sep 1815-7116
30 Jun 1814-7116
31 Mar 1813-6106
31 Dec 1711-7105
30 Sep 1710-695
30 Jun 1711-595
31 Mar 1711-374
31 Dec 1612-274
30 Sep 1611-374
30 Jun 169-264
31 Mar 168-474
31 Dec 157-464
30 Sep 156-555
30 Jun 155-556
31 Mar 154-546
31 Dec 143-746
30 Sep 143-535
30 Jun 142-534
31 Mar 142-524
31 Dec 131-724
30 Sep 131-924
30 Jun 130-1024

Quality Earnings: BRSY.F is currently unprofitable.

Growing Profit Margin: BRSY.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BRSY.F is unprofitable, and losses have increased over the past 5 years at a rate of 3.2% per year.

Accelerating Growth: Unable to compare BRSY.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BRSY.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: BRSY.F has a negative Return on Equity (-10.09%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.